Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 9, 2020
Retrospective study evaluating the safety of administering pegfilgrastim on the final day of 5-fluorouracil continuous intravenous infusionAmber S Draper, Jennifer Lafollette, Chaejin Kim, et al.
Gastrointestinal Cancer Research : GCR|October 3, 2014
Maintenance therapy with capecitabine in patients with resected pancreatic adenocarcinoma after adjuvant therapy: a retrospective cohort studyBenjamin A Weinberg, Hongkun Wang, Xuezhong Yang, et al.
JCO Oncology Practice|May 20, 2020
Provider Recommendations for Phase I Clinical Trials Within a Shared Decision-Making Model in Phase I Cancer Clinical Trial DiscussionsRachel S Hianik, Gavin P Campbell, Eli Abernethy, et al.
The Journal of Surgical Research|April 4, 2020
Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database StudyNosayaba Enofe, Andrew D Morris, Yuan Liu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2023
Changes in Prescribing Patterns in Stage III Colon CancerFang-Shu Ou, Daniel J Walden, Joseph J Larson, et al.
JAMA|August 3, 2026
Addition of High-Dose Vitamin D3 to Standard Treatment in Patients With Metastatic Colorectal Cancer: The SOLARIS Randomized Clinical Trial (Alliance A021703)Kimmie Ng, Fang-Shu Ou, Tyler Zemla, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2016
Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic AdenocarcinomaAnne M Noonan, Matthew R Farren, Susan M Geyer, et al.
Cancer|October 18, 2018
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapyMehmet A Bilen, Dylan J Martini, Yuan Liu, et al.
Investigational New Drugs|February 7, 2019
Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trialsDylan J Martini, Yuan Liu, Julie M Shabto, et al.
Cancer|October 25, 2019
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trialsDylan J Martini, Meredith R Kline, Yuan Liu, et al.
Pageof 2